Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer.
J. Clin. Oncol 2013 Jul 29;[EPub Ahead of Print], IB Vergote, R Chekerov, F Amant, P Harter, A Casado, J Emerich, T Bauknecht, K Mansouri, SP Myrand, TS Nguyen, P Shi, J SehouliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.